Excess weight and efficacy of anti-PD-1 antibodies in advanced cancer patients
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz253.112
Abstract: Abstract Background Immunotherapy is a new and effective form of therapy in several types of cancer, although molecular predictors of response are limited. Recently, we have described that immune-related adverse-events (irAEs) are significantly associated with… read more here.
Keywords: antibodies advanced; efficacy; excess weight; cancer ... See more keywords